Dr. Francesco Rubertis is an Angel Investor. Dr. Rubertis was a Board Member at Sequenta. rancesco is a partner at Index Ventures in the firm's life sciences practice. He joined Index in 1998 and has served on the board of numerous companies including Genmab, Bioxell, Addex, Parallele, 7TM and Pangenetics. Prior to joining Index, Francesco was involved in post-doctoral research in genetics at the Whitehead Institute, Massachusetts Institute of Technology (MIT). He is also the author of several publications in international scientific journals. Francesco has a BA in Genetics and Microbiology from the University of Pavia and a PhD in Molecular Biology from the University of Geneva. He is also a CFA charter holder.